Successful pallidal deep brain stimulation in 15-year-old with Tourette syndrome: 2-year follow-up

2013 ◽  
Vol 260 (9) ◽  
pp. 2417-2419 ◽  
Author(s):  
João Massano ◽  
Cláudia Sousa ◽  
Tom Foltynie ◽  
Ludvic Zrinzo ◽  
Marwan Hariz ◽  
...  
2017 ◽  
Vol 43 (1) ◽  
pp. E2 ◽  
Author(s):  
Victor Goulenko ◽  
Paulo Luiz da Costa Cruz ◽  
Paulo Niemeyer Filho

Pallidal stimulation has been the usual surgical treatment for dystonia in the last decades. The continuous investigation of the physiopathology and the motor pathways involved leads to the search for complementary targets to improve results. The authors present the case of a 37-year-old woman who had suffered from idiopathic hemidystonia with hyperkinetic and hypokinetic movements for 11 years, and who was treated with deep brain stimulation. A brief literature review is also provided. The globus pallidus internus and the ventral intermediate/ventral oral posterior complex of the thalamus were stimulated separately and simultaneously for 3 months and compared using the Burke-Fahn-Marsden Dystonia Rating Scale and the Global Dystonia Severity Rating Scale, with a 3.5-year follow-up. The synergism of multiple-target stimulation resulted in a complete improvement of the mixed dystonic symptoms.


2012 ◽  
Vol 11 (12) ◽  
pp. 1029-1038 ◽  
Author(s):  
Jens Volkmann ◽  
Alexander Wolters ◽  
Andreas Kupsch ◽  
Jörg Müller ◽  
Andrea A Kühn ◽  
...  

2012 ◽  
Vol 154 (11) ◽  
pp. 2029-2041 ◽  
Author(s):  
M. Porta ◽  
D. Servello ◽  
C. Zanaboni ◽  
F. Anasetti ◽  
C. Menghetti ◽  
...  

2018 ◽  
Vol 128 (2) ◽  
pp. 596-604 ◽  
Author(s):  
Richard S. Dowd ◽  
Michael Pourfar ◽  
Alon Y. Mogilner

OBJECTIVETourette syndrome (TS) is a complex neuropsychiatric disorder characterized by multiple motor and phonic tics. While pharmacological and behavioral therapy can be effective in most patients, a subset of patients remains refractory to treatment. Increasing clinical evidence from multiple centers suggests that deep brain stimulation (DBS) of the medial thalamus can be effective in many cases of refractory TS.METHODSThe authors retrospectively reviewed outcomes in 13 patients with refractory TS who underwent medial thalamic DBS performed by their team over a 7-year period. Patients were evaluated by a multidisciplinary team, and preoperative objective assessments were performed using the Yale Global Tic Severity Scale (YGTSS) and Yale-Brown Obsessive Compulsive Scale. YGTSS scores were calculated at visits immediately postoperatively and at the most recent follow-up in patients with a minimum of 6 months of postoperative follow-up. Coordinates of the active DBS contacts were calculated and projected onto each patient's pre- and postoperative images.RESULTSPatients showed an average decrease of 37% (p = 0.0063) in the total tic severity at their first postoperative visit. At their latest visit, their scores achieved significance, decreasing from preoperative scores by an average of 50% (p = 0.0014). The average position of the active contact was noted to be at the junction of the posterior ventralis oralis internus/centromedian-parafascicular nuclei. Device-related complications occurred in 2 patients, necessitating additional surgeries. All patients continued to use the system at last follow-up.CONCLUSIONSThe authors' data are consistent with the small but growing body of literature supporting DBS of the ventralis oralis internus/centromedian-parafascicular thalamus as an effective and relatively safe treatment for severe, refractory TS.


2020 ◽  
pp. 185-194
Author(s):  
Mitesh Lotia

The past two decades have revealed substantial benefits of bilateral pallidal deep brain stimulation (DBS) in patients with medication-refractory primary dystonia. There is a growing body of evidence now describing not only short-term but also long-term benefits up to 10 years following DBS. These benefits are often sustained, requiring minimal long-term modification. Pallidal programming for dystonia may be complex owing to the gradual onset of benefits and often delayed development of side effects. There is a relative scarcity of evidence-based recommendations for standardized programming methods. This chapter reviews essential factors to consider for appropriate patient selection and discusses strategies for initial and follow-up programming. Finally, the chapter describes the potential short-term and long-term adverse effects, while considering various strategies to mitigate them.


Sign in / Sign up

Export Citation Format

Share Document